Rec 1b: LT4 treatment goals include “(i) to provide resolution of the patients' symptoms and hypothyroid signs, including biological and physiologic markers of hypothyroidism, (ii) to achieve normalization of serum thyrotropin with improvement in thyroid hormone concentrations”. The gene discussed is TG; the disease is hypothyroidism.